Just a bit of news.
Oxford as we know has restarted and is in late stage 3. So with luck we may know before Christmas.
The reason we hear so much about Oxford is that it is entirely British and we are very likely to have that vaccine.
The Glaxo one, part of which is being developed in the U.K. but American, and which my daughter is working on is different from the Oxford because they are attaching an adjunct onto the protein (belt and braces). That is to boost the immune system, because at the moment anti-bodies only seem to be giving us about 4 months or so immunity. The vaccine will hopefully be a yearly one.
Glaxo is just started stage 3 so is a bit behind.
Excuse my explanation any scientists amongst you, as you might gather I am not a scientist, and trying to remember what was daughter was saying.